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Looking at the chapter on ‘‘natural history” in any tuberculosis (TB) reference book, there is
a kind of certainty regarding TB in adults. That is the concept of ‘‘post-primary” TB
described as the reactivation of dormant bacilli hidden in an old lesion developed during
infancy due to a type of local immunosuppression. Intriguingly, this concept involves at
least two major uncertainties: how can dormant bacilli remain for such a long period,
almost a lifetime, in an old lesion, taking into account granuloma dynamism; andwhat sort
of local immunosuppression is the one that facilitates reactivation? The controversy
between reactivation and exogenous reinfection as the cause of active TB started very soon
in TB research. Interestingly, this ‘‘balance” was disturbed in the 1960s when the ‘‘Unitary
Concept” became very successful in supporting the reactivation dogma. The ‘‘Unitary Con-
cept” was mainly based on the data of tuberculin surveillance during the pre-antibiotic era
as well as the data obtained from experimental modelling in animals. At the same time, the
‘‘Three-risks model” appeared to explain the relationship between the risk of infection and
TB incidence, granting reinfection a key role in adult TB together with primary infection.
This role was reinforced by the studies of recurrence based on molecular epidemiology,
and a better knowledge of the immune response, granuloma dynamics, and lung physiol-
ogy. Now it is a matter of taking it into account when designing new prophylactic and ther-
apeutic strategies and also reflecting it in text books to better illustrate to our students.
 2016 Asian-African Society for Mycobacteriology. Production and hosting by Elsevier Ltd.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).Introduction—‘‘The Unitary Concept The author of this theory, William Stead, introduced theReviewing the origin of the dogma of reactivation of an old
lesion as the main source of tuberculosis (TB) in adults, it
appears that this theory was written to convince the scientific
community about the rarity of exogenous reinfection in TB.topic citing the publications written by several authors
around the 1920s supporting the role of exogenous reinfec-
tion, putting it on a par at least with the exacerbation of dor-
mant foci [1]. In particular, the author cited several German
specialists (i.e., Assmann, Redeker, and Braeuning) that sup-
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adult TB (also called as chronic pulmonary TB). They named
this concept ‘‘The New Theory” and soon after, several Amer-
ican doctors (i.e., Opie, Pinner, Myers, Longe, Medlar, and Ter-
plan) supported it, to the point it was included in the
Diagnostic Standards and Classification of the National Tuber-
culosis Association [2]. The ‘‘New Theory” was based on the
experience of the wide use of roentgenograms, which started
during the First World War to identify TB among the soldiers
[3], and was thereafter used mainly for the control of thera-
peutic pneumothorax. With this technology, they found the
‘‘early infiltrates” not detectable by physical examination.
These minimal lesions were detected in heavily exposed
young adults (nurses or medical students) as they were
assumed to have been previously infected in childhood, and
the German doctors concluded that those early infiltrates in
the upper lobes were the consequence of exogenous
reinfection.
However, several Scandinavian specialists posed a strong
argument against ‘‘The New Theory”. According to the tuber-
culin skin test (TST) surveys among nursing and medical stu-
dents between 1920 and 1930, there were a considerable
number of patients who underwent TST. They then supported
the concept that the majority of TB cases in adults, consid-
ered to be caused by reinfection, were actually cases of pro-
gression of recent primary infections [4].
Does TB incidence depend only on tuberculin
status?
Stead considered that the main argument to determine the
role of reinfection in adult TB incidence was to compare the
incidence of TB between heavily infected persons (close con-
tacts), considering their TST status, and non-exposed persons
(control group) in order to relativize the factor of reinfection.
He used data from the pre-antibiotic era [5–7]. Interestingly,
he found that previous TST-positive (+) persons had a signif-
icantly lower incidence of TB in both groups than TST-
negative (–) persons. In particular, the ratio between close
contacts and controls in TST+ was approximately 2,
whereas that in TST was approximately 5 (Table 1). Sur-
prisingly, the author considered the higher TB incidence in
close contacts of the TST+ group irrelevant, arguing that the
contact group was mainly integrated by nursing and medical
students. According to Stead, this group developed more TB
because they were subjected to ‘‘longer working hours and
greater bodily fatigue” than the TST+ control group.
Therefore, he considered this higher ratio of re-exposure
(exogenous reinfection) irrelevant to the TB incidence inTable 1 – Incidence (rate/1000 person-years) of Tuberculosis
in Different TST groups [5–7].
Close contact Control
TST+ 7.6* 4.3*
TST– 49.4** 10.8**
Note. TST = tuberculin skin test.
* p < .05.
** p < .01.TST+ persons and concluded that the most important risk
in TST+ persons was reactivation.What is the upper lobe scenario about?
This idea concludes that TB in adults is mainly the conse-
quence of an old lesion in the apex, induced after the
hematogenous dissemination that takes place following pri-
mary infection. This is in contrast to primary lesions, which
usually occur in the middle or lower lobes. Stead used the
presence of lesions in the upper lobes in 20% of autopsies of
patients with successfully controlled primary lesions [1] as
an argument to support this; the other argument was that
such lesions tend to have more active bacilli and to be more
prone to reactivation than the primary lesions. Following
the criteria of the Scandinavian authors [4], the author also
favored the possibility that typical adult lesions could occur
after a primary infection in the upper lobe, as has recently
been demonstrated using molecular epidemiology tools [8].
In this regard, it is important to bear in mind that the
upper lobes represent 20% of the lung volume [9,10], so the
presence of such lesions is exactly what should be expected.
Stead also supported the concept that the most common
site for metastatic implantations is the pulmonary apex
because the very high oxygen tension provides a favorable
milieu for the bacilli. High oxygen pressure is precisely a con-
sequence of low blood perfusion. Therefore, lesion localiza-
tion should be less important at this site. It has been clearly
demonstrated that TB lesions progress more in the upper
lobes [11,12]. The fact is that, in the upper lobes, there is a
small breathing amplitude which favors an increased local
bacilli–alveolar macrophages ratio leading to an excessive
inflammatory response; this in turn favors the recruitment
of neutrophils and the induction of exudative lesions. These
lesions are the ones that are able to grow quicker and avoid
encapsulation by the interlobar septae. Thus, active disease
can be induced [13] by local dissemination of new daughter
lesions that will finally coalesce, also aided by exogenous
reinfection [14]. Equally, the higher tension borne by these
septae, as a consequence of the force of gravity, makes these
structures less reactive against the presence of local lesions.
An interesting and very ‘‘graphic” observation was described
in miliary TB cases where the lung nodules are larger in the
upper lobes than in the lower [15–17].Lymphatic and hematogenous dissemination as a
source of pulmonary and extrapulmonary lesions
After a primary infection, there is a delay in the immune
response, and thus, the bacillary bulk that reaches the drain-
ing lymph nodes is higher than that in the presence of a pre-
vious immune response. In addition, the lymph node is not
homogenous at all; in fact, there is a proximal site where
macrophages are infected and a real infection is developed,
and there is a distal site where dendritic cells are affected,
generating the specific lymphocytes. Fortunately, these lym-
phocytes do not go directly to the infected site of the lymph
node; they reach the cava vein, the right heart, and the lung
again where they are attracted to the infected sites and
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control of these lesions, and there is an ‘‘excess” of lympho-
cytes, they reach the infective site of the lymph nodes.
Thanks to this mechanism, the bacillary load is controlled
earlier in the lung than in the organ that generates the protec-
tion, the lymph node. Meanwhile, the infection of the lymph
nodemay overwhelm its capacity, and some of the bacilli may
also reach the right heart and generate new lesions in the
lungs [18].
The presence of extrapulmonary lesions (other than lung
lymph nodes) requires a direct shunt toward the arterial cap-
illary. This is the only way to reach the left atrium, the left
ventricle, and the systemic vessels. It requires a large lesion
and the induction of an important neovascularization pro-
cess. As happens with tumors, there is also a lymphatic net-
work surrounding the neovascularization that drains the
bacilli to the lymph node again; however, the new blood cap-
illaries are more permeable and fragile than the regular ones,
increasing the chances of bacilli reaching extrapulmonary
sites. In fact, it has been demonstrated recently that Mycobac-
terium tuberculosis (Mtb) is a great inducer of neovasculariza-
tion [19]. On the other hand, dissemination in the lungs also
benefits the development of bigger lesions. It has been very
well demonstrated in the zebrafish model that disseminating
bacilli tend to reach the sites which are already infected both
because of the increased perfusion due to the inflammatory
response and also because of the quality of the capillary net-
work that increases the frequency of particle accumulation
[20].
In conclusion, dissemination is more likely to occur in per-
sons with a delayed immune response, such as children or
immunodepressed persons, where it has the particularity of
affecting the lymph nodes, contrary to what happens in
immunocompetent persons. This has been recently demon-
strated using molecular epidemiology and comparing atypical
with typical radiological parameters [8]. Even so, it is still
widely accepted that these patrons are linked to primary
and post-primary (i.e., after a reactivation of an old lesion)
forms of TB, respectively.
‘‘Dynamic hypothesis versus resuscitation from
old lesions
Dormant bacilli from TB lesions are drained towards the
upper bronchi with the alveolar fluid and from there toward
the pharynx and the stomach where they are destroyed.
The clearest evidence for this is the use of gastrointestinal
lavage in children to detect bacilli, even when they suffer
from noncavitary pulmonary TB lesions [21]). This has been
one of the arguments used to defend the ‘‘dynamic hypothe-
sis” (i.e., the constant endogenous reinfection that maintains
the latent infection) [22].
Mtb is not the only bacterium that is able to resist and per-
sist under stress conditions. In fact, this occurs across the
whole spectrum of bacteria [23], and therefore, it is not
uncommon. What is peculiar is that chemotherapy (isoniazid
[INH]), which is only active against growing bacilli, would
have any activity against dormant bacilli, the ones responsi-
ble for maintaining the latent infection [24]. The only expla-nation here again comes from the ‘‘dynamic hypothesis”
based on the constant drainage of bacilli. Consequently, as
has been proven experimentally, there is a chance of reinfect-
ing the parenchyma by the production of infective aerosols
from the infected alveolar fluid. Considering that INH shows
its maximum activity during the first 15 days of treatment,
due to its capacity to kill actively growing bacilli [25], the only
explanation for such a prolonged period of INH administra-
tion would be to avoid the endogenous reinfection process
by keeping bactericidal levels constant to kill the growing
bacilli that may induce secondary lesions.
Stead did not acknowledge this discrete drainage from
‘‘controlled” lesions; he only considered the local drainage
of infective material coming from large, apparent lesions.
As a consequence, he could not imagine that in ‘‘dormant
lesions” like the ones of the upper lobes, there is a constant
drainage of the dormant bacilli; therefore, the risk of reactiva-
tion is reduced over time. Furthermore, these lesions tend to
calcify, thereby drastically reducing their bacillary load [26].
Influence of experimental modeling
Stead also based his theory on data from experimental animal
models. In this case, size is very important. Mice, guinea pigs,
or rabbits have a very small lung surface area. One of the con-
sequences is that the detection of new lesions by the immune
response is far easier in them than in big mammals, like
humans, where the surface area is equivalent to a tennis
court [27] and where the distances between the different
lesions can be huge. This makes the constant establishment
of new lesions more likely, especially considering that protec-
tion against TB requires at least a conserved Th1 cellular
response, as the AIDS epidemic has dramatically shown. Con-
trary to what would happen with antibody-mediated protec-
tive immunity, lesions must be found by the specific
lymphocytes, and this requires the induction of a local
inflammatory response to attract them. As the local inflam-
matory response requires some time in the case of Mtb infec-
tion, the bacilli have the chance to constantly reinfect ‘‘virgin”
areas. Hence, TB lesions can be found in various stages of
progression.
Lessons learned from contact tracing
Another piece of evidence comes from the main risk of
acquiring active TB: to be in close contact with a patient. This
means at least >6 h a day for a period that depends on the
diagnostic delay, around 60–90 days [28]. Does this mean that
induction of the infection is rare or on the contrary, does this
mean that during this period, the contact is infected on mul-
tiple occasions and consequently is more likely to induce
active TB? Likewise, what happens in countries with a high
incidence, the Republic of South Africa, for instance? Does it
mean that people with active TB have been infected just
once? Or that they are constantly being reinfected and, there-
fore, have a higher chance of developing active TB? The paper
showing children who developed sensitive TB, although they
were in close contact with their parents suffering from
multidrug-resistant TB, is just an illustration of this complex-
Fig. 1 – Origin of the 5-year period for developing
tuberculosis after infection. Incidence of tuberculosis in
unvaccinated TST convertors in the MRC Tuberculosis
Vaccination Trial [37]. Out of 35,000 unvaccinated adoles-
cents, there were 2170 TST convertors, of which 113
developed tuberculosis. Note. TST = tuberculin skin test;
MRC = Medical Research Council. Adapted from: Vynnycky
E, Fine PE. The natural history of tuberculosis: the implica-
tions of age-dependent risks of disease and the role of
reinfection. Epidemiol Infect [Internet]. 1997 Oct [cited 2016
Sep 8];119(2):183–201.
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fact, Stead also explains a case like that in his paper [1]. Ignor-
ing this factor has led to a curious phenomenon, for instance,
in the design of new vaccines: they are designed against only
one single challenge [30]. In this regard, other authors have
started to work on the concept of multiple consecutive infec-
tions and are trying to understand, for instance, the inefficacy
of bacillus Calmette–Gue´rin vaccine (BCG) in countries with a
high risk of infection [31]. It is also important to note that
infection confers some protection, similar to what is obtained
by BCG vaccination, at least in terms of control of the bacillary
load, as has been demonstrated by experimental modeling
[32,33]. This is an interesting point to consider in the contact
tracing strategy. To look for TSTmight have a limited value for
the prediction of active TB in groups with a high prevalence of
TST+. Again, in this regard, TST has only some predictive
value in the converters, as we will discuss in the next chapter.
Reinfection has a place when trying to understand
the whole picture
At the same time when Stead was preparing his paper, a little
‘‘revolution” started at the other side of the Atlantic, at the
Royal Netherlands Tuberculosis Association (KNVC), where
the first attempts to understand the whole TB epidemiology
picture started in 1965. In particular, it was in the context of
‘‘The International Tuberculosis Surveillance Research Unit
(TSRU)” supported by KNVC and the abundant epidemiologi-
cal data from the Netherlands andwith Dr. Karel Styblo as the
first Principal Investigator [34]. Among the several findings
produced by the TSRU were the epidemiological indexes: (a)
the annual risk of infection; (b) the ratio between the annual
risk of infection and the incidence rate of infectious (smear
positive) cases; and (c) the risk of progression from infection
to disease and the issue of endogenous reactivation (or exac-
erbation) versus exogenous origin of the development of TB.
It was against this background that, using the proposal of
Dr. Johannes Holm at a TSRU meeting in 1969 and the first
exploratory analysis performed by Dr. K. Styblo, Sutherland
et al. [37], from the British Medical Research Council (MRC)
published several papers related to a pioneer model to fit
the annual risk of infection with TB disease incidence using
the epidemiological data from the Netherlands [26,35,36].
Thus, he established the ‘‘Three-risks model” for TB disease,
stating that (1) those with a recent primary infection had a
characteristic risk of developing progressive primary tubercu-
losis, (2) those with a distant (i.e., not recent) primary infec-
tion and a recent reinfection had a characteristic risk of
developing exogenous tuberculosis, and (3) those with a dis-
tant primary infection, but no recent reinfection had a char-
acteristic risk of developing endogenous tuberculosis.
In particular, Sutherland established the border between
recent and distant at 5 years, taking into account his own
data as investigator of the MRC Tuberculosis Vaccine trial that
enrolled 35,000 unvaccinated adolescents. In this study, they
identified a group of 2,170 TST converters, of whom 113
(5.2%) developed TB. In particular, the cumulative incidence
was of 58% (1st year), 80% (2nd year), and almost 100% (5th
year) with no incidence after 8 years [37] (Fig. 1).This data is in agreement with the duration of the INH
treatment as chemoprophylaxis. It offers an efficacy of 90%
after 9–12 months of treatment [38]. It can be interpreted that
during this time, 90% of the dormant bacilli have been
drained from the lesions, and INH has avoided the possibility
of secondary lesions being induced and causing active TB. In
this regard, it can be considered that INH treatment acceler-
ates the drainage ratio after the first killing of growing bacilli
(up to a 90% of the bacillary load), thus considerably reducing
this period compared with the natural draining process. In
this case, taking into account the data of the MRC [37],
approximately 3 years are needed to drain the same percent-
age of dormant bacilli (Fig. 1).
Although the ‘‘Three-risks model” has been refined by
other authors, none of them have considered the incidence
of ‘‘residual TB,” those patients that have suffered TB and
have not been properly treated with chemotherapy. These
patients have large lesions with no definitive fibrosis and cal-
cification and with a high percentage of viable dormant
Fig. 2 – Relationship between Risk of Infection and Incidence of Tuberculosis. This is a refinement of the ‘‘Three-risks model”
proposed by Vynnykcy and Fine [39] to include the age variable. In this model, the incidence of reinfection is paramount in
order to fit the real data from tuberculosis incidence in England and Wales. Adapted from: Vynnycky E, Fine PE. The natural
history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection. Epidemiol Infect
[Internet]. 1997 Oct [cited 2016 Sep 8];119(2):183–201.
Fig. 3 – Reinfection Increases with an Increase in
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suffering their first episode. This is probably the reason for
an excess of the reactivation percentage in these models.
It is worth noting that Vynnycky and Fine included age
dependency in the model [39] (Fig. 2). They found that for
most age groups, the risk of developing the first primary epi-
sode after initial infection exceeded that of developing
endogenous and exogenous disease. Previous infection was
found to impart 16% and 41% protection against disease sub-
sequent to reinfection among adolescents and adults, respec-
tively, but little protection against reinfection.
Reinfection is, thus, an important event with largely
unknown consequences; for example, it can be speculated
that multiple exposures may even precipitate progression to
disease. Thus, the influence of incidence on the reinfection
rate appears to be a fundamental issue [40] (Fig. 3).
Tuberculosis Incidence. Data from Uys et al. [40] relating the
risk of reinfection with tuberculosis incidence, adjusting the
‘‘Three risks model” with the reinfection data obtained by
Wang et al. [47]. Adapted from: Uys PW, van Helden PD,
Hargrove JW. Tuberculosis reinfection rate as a proportion of
total infection rate correlates with the logarithm of the
incidence rate: a mathematical model. J R Soc Interface
[Internet]. 2009 Jan 6 [cited 2016 Sep 8];6(30):11–5.Study of recurrence: relapse versus reinfection
Adequately treated patients are still at a high risk of develop-
ing recurrent pulmonary disease (defined as an episode of TB
following the cure of a previous episode). Recent estimates for
the recurrence rate of TB across different regions point to an
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treatment completion. In high-incidence regions, the average
TB recurrence rate can reach 7,850/100,000 person-years [41].
The issue of whether or not a first episode of TB imparts
some measure of immunity to further TB infections has not
been unequivocally established, but it may have an impact
[42,43]. On the other hand, a potential confounding effect is
that a patient experiencing a second episode of TB may sim-
ply be demonstrating that he/she has a higher susceptibility,
either innate or due to environmental conditions [44,45]. It
is also possible that an episode of TB actually renders the
patient more susceptible to infection or likely to become ill.
All these issues are surveyed in Verver et al. [42].
The study of recurrence has provided new evidence on the
role of reinfection as DNA fingerprinting can be used to eval-
uate the homology between the strain that caused the first
episode and the recurrent one. However, this concept can
hide an important percentage of reinfections by strains that
are very prevalent in the community and cannot be distin-
guished from the one obtained from the first episode.
In spite of this limitation, it was soon appreciated that
exogenous reinfection may be the origin of a majority (up to
90%) of disease cases in regions with a high risk of infection
[40,46,47].
Even so, exogenous reinfection tends to be related to
regions with a high incidence; therefore, it is not being con-
sidered in those with a low incidence. This has led to the
use of network models of TB transmission where the popula-
tion is not homogeneous, and thus, taking into account that
individuals are more likely to be in contact with those with
whom they share a home, a school or a workplace than with
those with whom they have no particular contact [48]. This
approach has demonstrated that in large communities with
low TB incidence, nonrandom mixing of the population
means that reinfection may play a larger role in disease
dynamics than previously recognized. This result does not
depend on the explicit inclusion of subpopulations with com-
promised immunity or otherwise distinctive disease risk. Pro-
longed or intense contact, such as the interactions occurring
within closed settings like households, workplaces, and hos-
pitals, is generally considered necessary for transmission of
Mtb.
It is well known that some groups have much higher risk
of acquiring infection and developing disease than the major-
ity of the population: (1) incarcerated prisoners (20 times
higher in Brazil) [49]; (2) persons living with HIV (8 times
higher in a South African community) [50]; and (3) geograph-
ical hotspots within urban settings (3 times higher in people
living in the poorest areas in Rio de Janeiro) [51], among
others.
It has been shown that in a high-incidence setting near
Cape Town, South Africa, the rate of reinfection TB disease
after the cure of a previous TB disease episode is about four
times greater than the rate of first-time TB disease. It is not
known whether this elevated rate is caused by a high reinfec-
tion rate due to, for instance, living circumstances, or a high
rate of progression to disease specific to the patients, or both.
In order to address this question Uys et al. [52] analyzed an
extensive data set from clinics attended by patients with TBin a high-incidence setting near Cape Town, South Africa,
and found that, in fact, the (average) rate of reinfection (as
opposed to the rate of reinfection disease) after the cure of
a previous TB disease episode is initially about 0.85 per
annum. This rate diminishes rapidly over time, and after
about 10 years, this rate is similar to the rate of infection in
the general population. In addition, the rate of progression
to disease after reinfection is initially high but declines in
subsequent years down to the figure typical for the general
population. These findings suggest that the first few months
after the cure of a TB disease episode form a critical period
for controlling reinfection disease in a hyperendemic setting
and that monitoring such cured patients could preempt a
reinfection progressing to active disease.
Conclusion
The support to reactivation as the main source of TB is adults
have a series of weak points. Having analyzed these, this
review concludes that exogenous reinfection together with
primary infection appear to be the major sources of adult
TB, contrary to what is usually cited in TB reference books.
According to the data shown, active TB is developed during
the first 2 years after infection or even after recurrence being
almost impossible for it to occur after 5 years. This is
explained by the constant drainage of the dormant bacilli
from the lesions and the progressive destruction of the per-
sisting ones with calcification. This process can be acceler-
ated with INH chemoprophylaxis, with the initial killing of
growing bacilli and avoiding the induction of further sec-
ondary lesions, reducing the probability of developing active
TB after 9–12 months’ treatment up to 10%; the natural pro-
cess requires a period of 3 years.
Reinfection is possible because the type of immune
response required, cell-mediated immunity, needs a certain
local inflammatory response to locate lesions. This fact is
easy to perceive with the presence of lesions in different
stages of progression in the same individual.
The data on DNA fingerprinting in recurrence also points
towards the greater importance of the reinfection process,
considering the presence of different fingerprints between
the strains of the initial disease and the subsequent ones.
Even so, this process is unable to precisely identify the most
prevalent strains, which must be the ones with a higher inci-
dence in the initial process and naturally in the subsequent
ones.
Finally, even if it may be true that reactivation is possible,
there is another factor, which has previously not been consid-
ered and is usually not recorded, that is, the prevalence of
spontaneously healed TB (without chemotherapy), because
of the large area affected, which probably behaves as residual
or silent TB and which may eventually recrudesce at
advanced ages. This is precisely observed in countries with
low incidence.
Overall, the impression is that reinfection should be con-
sidered as the major source of adult TB in high-incidence
countries, and together with primary disease, in low-
incidence countries. This concept should aid the develop-
ment of better strategies for TB control.
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